MENU
ESPR
AS OF
Dec 12 closing price
Price
$3.85
Change
-$0.23 (-5.64%)
Capitalization
912.72M
72 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ESPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Esperion Therapeutics (ESPR) Ownership - Who owns Esperion Therapeutics?

Esperion Therapeutics Inc is a pharmaceutical company... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
912.72M
P/E Ratio
N/A
Total Cash
92.45M
Projected Growth
N/A
Total Debt
306.8M
Revenue
303.8M
Risk (Beta)
3.62
Dividend Yield
N/A
Total Cash/Share
0.39
Total Debt/Equity
N/A
Revenue/Share
1.54 USD as % of share price

Fundamentals

ESPR
Capitalization
913M
P/E Ratio
N/A
Risk (Beta)
3.62
Dividend Yield
N/A
Total Cash
92.4M
Total Cash/Share
0.39
Total Debt
307M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.54%
Revenue
304M
ROE
N/A
Book Value
-451.36M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
205K
Current Ratio
1.00
Current Revenue Per Employee
287200.66
Dividends Per Share - Security
N/A
EBITDA
-27.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
52.71
Revenue To Assets
-31.21
Shares Held By Institutions
393M
Shares Outstanding - Current
237M
Total Liabilities
815M
Total Volume MTD
N/A
Value
N/A
Gain YTD
85.455
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ESPR
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ESPR showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ESPR
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com